Display options
Cite
Bosch W, Cowart JB, Bhakta S, et al. COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab932.
Bosch, W., Cowart, J. B., Bhakta, S., Carter, R. E., Wadei, H. M., Shah, S. Z., Sanghavi, D. K., Pollock, B. D., Neville, M. R., Oman, S. P., Speicher, L., Scindia, A. D., Matson, M. W., & Moreno Franco, P. (2021). COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab932
Bosch, Wendelyn, et al. "COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab932
Bosch W, Cowart JB, Bhakta S, Carter RE, Wadei HM, Shah SZ, Sanghavi DK, Pollock BD, Neville MR, Oman SP, Speicher L, Scindia AD, Matson MW, Moreno Franco P. COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021. Clin Infect Dis. 2021 Nov 02; doi: 10.1093/cid/ciab932. Epub 2021 Nov 02. PMID: 34726700.
Copy Download .nbib Format: NLM
Share it on

Clin Infect Dis. 2021 Nov 02; doi: 10.1093/cid/ciab932. Epub 2021 Nov 02.

COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Wendelyn Bosch, Jennifer B Cowart, Shivang Bhakta, Rickey E Carter, Hani M Wadei, Sadia Z Shah, Devang K Sanghavi, Benjamin D Pollock, Matthew R Neville, Sven P Oman, Leigh Speicher, Ameya D Scindia, Mark W Matson, Pablo Moreno Franco

Affiliations

  1. Division of Infectious Diseases, Mayo Clinic, Jacksonville, Florida, United States of America.
  2. Division of Hospital Internal Medicine, Mayo Clinic, Jacksonville, Florida, United States of America.
  3. Department of Critical Care Medicine, Mayo Clinic, Jacksonville, Florida, United States of America.
  4. Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida, United States of America.
  5. Division of Nephrology, Mayo Clinic, Jacksonville, Florida, United States of America.
  6. Department of Transplantation, Mayo Clinic, Jacksonville, Florida, United States of America.
  7. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Jacksonville, Florida, United States of America.
  8. Division of General Internal Medicine, Mayo Clinic, Jacksonville, Florida, United States of America.
  9. Center for Digital Health - Data & Analytics, Mayo Clinic, Rochester, Minnesota, United States of America.

PMID: 34726700 DOI: 10.1093/cid/ciab932

Abstract

We characterized COVID-19 breakthrough cases admitted to a single center in Florida. With the emergence of delta variant, an increased number of hospitalizations was seen due to breakthrough infections. These patients were older and more likely to have comorbidities. Preventive measures should be maintained even after vaccination.

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].

Keywords: COVID-19; breakthrough infection; hospitalizations; vaccine; vaccine-breakthrough; variants of concern

Publication Types